Neuroblastoma (NB) is a childhood malignancy originating from neural crest cells, which seldom occurs in association with other neurocristopathies. Owing to the rarity of familial NB cases, only a few linkage data are available and no mutations in candidate genes have been demonstrated up till now. Germline mutations in a small proportion of NB patients have been recently reported in the paired-like homeobox 2B (PHOX2B) gene, suggesting its role in NB predisposition. On the basis of this indication, we screened three Italian families with recurrence of NB and one family with occurrence of ganglioneuroblastoma and isolated Hirschsprung disease for PHOX2B defects. Our analysis did not show any mutation, excluding PHOX2B as the NB susceptibility gene in the families we analysed. Our findings combined with those derived from other PHOX2B mutation screenings and from genome-wide linkage analysis support a remarkable genetic heterogeneity of NB and suggest an oligogenic model of disease transmission. Furthermore, as PHOX2B mutations were mainly observed in some NB families with multifocal and syndromic NB, features that are missing in the families we have studied, we suggest they represent second-site modifications responsible for a specific phenotype rather than causal mutations of a major locus.
Neuroblastoma (NB) is a childhood malignancy affecting neural crest deriving cell lineages, rarely occurring in association with Hirschsprung disease (HSCR) and/or congenital central hypoventilation syndrome (CCHS) (Croaker et al., 1998) . Familial NB accounts for only 1-1.5% of all cases and pedigrees show patients either distributed along three generations or clustered in the most recent generation (Maris et al., 2002; Tonini et al., 2003) . To explain the rarity of familial clustering and the presence of multifocal tumours in familial NB, Knudson and Strong (1972) suggested an autosomal dominant mode of inheritance with incomplete penetrance and proposed a two-hit model of inherited predisposition to the disease.
The first observation of germline mutations transmitted along a pedigree in NB patients is reported by Trochet et al. (2004) for the paired-like homeobox 2B (PHOX2B) gene, which is considered an essential regulator in the development of autonomic neural crest derivatives (Pattyn et al., 1999) . The French study describes two different missense mutations of PHOX2B: a transversion c.299G>T was found in a family with an NB and two ganglioneuroma (GN), one of which multifocal, and a transversion c.421C>G was found in a sporadic case of HSCR associated with NB, whereas another family with recurrent NB did not show any PHOX2B anomaly (Trochet et al., 2004) .
On the basis of these indications, we have attempted to verify the presence of PHOX2B mutations in three families with the recurrence of NB and one family with the occurrence of ganglioneuroblastoma (GNB) and isolated HSCR (Figure 1 ) by using a recently developed protocol (Matera et al., 2004) . Moreover, we have analysed six microsatellites of the Ge´ne´thon Human Linkage Map flanking PHOX2B at 4p12 (D4S405-D4S2919-D4S3045-D4S2974-D4S350-D4S1592) by PCR amplification with fluorescently labelled sense primers and separation in the automated sequencer ABI 3730 (Applied Biosystems, Foster City, CA, USA).
No mutations have been detected in the three exons of PHOX2B by analyzing constitutional DNA of the 10 NB patients and the one affected with HSCR ( Figure 1) . No haplotype segregation has been found at the genomic interval encompassing the gene or in its close vicinity. Therefore, our findings exclude that PHOX2B is the NB susceptibility gene in the families we analysed.
The different results obtained by us and by the French group confirm the remarkable genetic heterogeneity of NB and raise questions about the PHOX2B involvement in the genetic determination of the disease. Moreover, the two distinct missense mutations affecting the homeodomain in the mid-portion of the protein (Trochet et al., 2004) Therefore, in our opinion, the assumption that PHOX2B plays a primary role in NB predisposition cannot be suggested for all NB cases. It might rather be limited to a proportion of patients sharing specific phenotypic features like multifocal tumours and syndromic NB (Amiel et al., 2003; Weese-Mayer et al., 2003; Trochet et al., 2004 ).
Our hypothesis is further supported by a recent mutation screening (Mosse et al., 2004) that demonstrates a PHOX2B germline mutation (a heterozygous c.676delG) only in one of three generations of NB family, but does not show any evidence for mutation in eight other pedigrees. The family carrying a PHOX2B mutation shows a complex pedigree that includes seven patients: one with GN, four with multifocal NB, two with NB in association with HSCR, one of which having Figure 1 Pedigrees of NB families screened for PHOX2B mutations. Family IGG-E includes five affected children, first and second degree cousins. Patient IV-5 had a thoracic nodular GNB at stage 3 of disease. Other two patients had a stage 1 GNB (IV-20) and a stage 3 nodular GNB in the thoracic-abdominal region (IV-26), respectively. Patient IV-24 had a stage 4S adrenal NB with a lateralcervical mass and multiple hepatic and cutaneous lesions. All these patients had good prognosis and are currently in complete or partial remission. Differently, patient IV-14 is affected by a stage 4 lateral-cervical NB characterized by unfavourable histology, relapse and poor outcome. With respect to a previous publication (Perri et al., 2002a) , family IGG-E includes an additional patient (IV-14) who was affected with NB more recently. In family OIRM-C two second cousins were affected: patient IV-7 had a retroperitoneal GNB at stage 3 of disease and patient IV-12 presented a stage 4 adrenal NB with unfavourable histology. Family IGG-M includes an affected sib-pair, one with retroperitoneal NB at stage 4 with unfavourable histology who died of disease and the other with an NB at stage 2B who experienced relapse 3 and 8 years after diagnosis. Family HDC038 consists of a mother with GNB and a daughter with a long segment isolated form of HSCR (Griseri et al., 2000) . Stage of disease and morphologic tumour classification are listed according to the International Neuroblastoma Staging System (Brooleur et al., 1993) and the International Neuroblastoma Pathology Classification (Shimada et al., 1999) , respectively. Age: age at diagnosis; mo: months PHOX2B and familial neuroblastoma P Perri et al multifocal tumours and NF1 (Maris et al., 2002) . As the proband of this family was also shown to have an inactivating mutation in NF1, we also screened an NB patient with a constitutional NF1 mutation (Origone et al., 2003) and his parents without finding any PHOX2B mutation.
Very recently, six different frameshift PHOX2B mutations have been also identified in a series of 237 sporadic NBs and 22 cell lines (2.3%). Two of these are de novo constitutional mutations that were detected in two NB patients, one of whom was diagnosed with CCHS and HSCR (Limpt et al., 2004) .
The few linkage studies carried out over the years have not allowed the identification of NB predisposing genes as yet. These investigations showed evidence of linkage to markers at 16p12-13 in North American families (Maris et al., 2002) , whereas this interval was excluded (Perri et al., 2002b) and other loci at 4p16 were candidate for NB predisposition in European families (Perri et al., 2002a) including the IGG-E family of this study (Figure 1) . Noteworthy, the NB family with a segregating PHOX2B mutation described by the American group (Mosse et al., 2004) had previously been shown to be exclusively linked to the 16p12-13 interval (Maris et al., 2002) .
Combining the results obtained by PHOX2B mutation screenings (Limpt et al., 2004; Mosse et al., 2004; Trochet et al., 2004 ; the present study) with those achieved by linkage analysis and deletion mapping, the hypothesis of a single gene predisposing to NB cannot be supported. All these data further confirm the remarkable genetic heterogeneity of NB and reinforce the concept that an oligogenic mode of disease transmission, probably governed by a major susceptibility gene, is more appropriate to explain the genetic basis of familial NB Mosse et al., 2004) .
Though the oligogenic model is mainly involved to give an account of genetic predisposition of metabolic disorders and developmental malformation syndromes (Ming and Muenke, 2002; Katsanis, 2004) , it may explain the existence of different NB loci genetically interacting to cause and/or modify the disease-phenotype in different families.
Genetic heterogeneity and clinical variability of NB may imply the existence of a gene exerting the major effect and second-site genetic modifications modulating the penetrance and/or expressivity of recessive mutations at a primary locus. Alternatively, multiple genes may assume a synergic role in causing and/or modifying the disease phenotype. The oligogenic model is also consistent with multiple genetic hits and may involve both tumour suppressor and modifier genes. The contribution of the latter can also explain the high intra-familial phenotypic variation such as the presence of different histological tumour categories (i.e. GN, GNB and NB characterized by an increased degree of malignancy) (Shimada et al., 1999) described in some pedigrees (Maris et al., 2002 ; the present study, Figure 1 ). Phenotypic variations among patients of the same family such as severity, age at onset and progression rate of the disease as well as possible associations with other syndromes further support an oligogenic model. In this light, the PHOX2B mutations found in some NB families and not others may represent second-site modifications responsible for a specific phenotype rather than causal mutations of a major locus. This hypothesis is further supported by the observation that NB patients carrying PHOX2B mutations are affected with GN, multifocal tumours and syndromic NB, features that are missing in the families we have studied and in other pedigrees without segregation of PHOX2B mutations.
